Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 28, 2014; 20(4): 923-942
Published online Jan 28, 2014. doi: 10.3748/wjg.v20.i4.923
Published online Jan 28, 2014. doi: 10.3748/wjg.v20.i4.923
Figure 3 Advantages of a cancer stem cell-specific therapy compared to conventional anticancer therapies.
The current anticancer drugs wipe out most of the bulk population but the surviving cancer stem cells (CSCs) can repopulate the tumor. Specific targeting of CSCs is essential for regression and complete eradication of the tumor.
- Citation: Fanali C, Lucchetti D, Farina M, Corbi M, Cufino V, Cittadini A, Sgambato A. Cancer stem cells in colorectal cancer from pathogenesis to therapy: Controversies and perspectives. World J Gastroenterol 2014; 20(4): 923-942
- URL: https://www.wjgnet.com/1007-9327/full/v20/i4/923.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i4.923